The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.50
Bid: 133.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.256%)
Open: 133.00
High: 135.50
Low: 133.00
Prev. Close: 134.50
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM and COVID-19 Update

14 May 2020 07:00

RNS Number : 8340M
Eurocell plc
14 May 2020
 

14 May 2020

 

EUROCELL PLC

(Symbol: ECEL)

 

AGM and COVID-19 Update

 

Eurocell, the market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products, provides the following COVID-19 update ahead of its Annual General Meeting to be held at 3pm today.

 

Initial Actions in Response to COVID-19

As previously announced, performance in the 11 weeks to 20 March 2020 was in line with our expectations and there was no discernible impact on trading from COVID-19. Since then, our manufacturing plants, branch network, distribution and recycling operations have all been closed, in line with the official guidance from the UK Government.

 

Alongside the closure of our operations, we also took a number of significant, swift actions to conserve cash. These included the deferral of non-essential operating costs and the vast majority of planned capital expenditure whilst operations remained closed, and cancellation of the final dividend payment for the year ended 31 December 2019. Also as part of these actions, the Board and other members of the senior management team agreed to a 20% reduction in remuneration. In addition, we have continued to make use of various Government measures available, including the Coronavirus Job Retention Scheme.

 

Bank Facility and Share Placing

We have a strong balance sheet and were able to increase our bank facility to £75 million in March 2020. As previously disclosed, we continue to believe our banks will be supportive of reviewing covenants, if required.

 

Given the ongoing uncertainty of the COVID-19 situation, on 1 April we raised approximately £17.6m by way of a share placing. Net proceeds will be used to ensure we retain headroom on our bank facility, even under an extended shut-down, and to provide sufficient liquidity for investment in our new state-of-the-art warehouse. As well as being key to increasing total capacity, the new warehouse will deliver improved operational efficiencies. Good headroom on our bank facility will ensure the business is well placed to capitalise on opportunities when markets re-open.

 

Re-opening Plans

We are now pleased to announce that, following the latest guidance from the Government, which permits tradesmen to work in domestic dwellings so long as appropriate precautions are taken, we have implemented the first steps towards re-opening the business. On 11 May we recommenced supply to our fabricator customers from existing stocks and opened six branches around the country. This is allowing us to test our safe-working practices and begin to assess the level of customer demand.

 

We are encouraged that trading over the first three days has been robust, although it is not yet clear whether this is a result of pent up or underlying demand. Subject to the on-going results from these activities, and in particular there being sufficient underlying demand, we plan a phased re-opening of the business over the coming weeks. This includes a return to manufacturing when required to ensure continuity of supply to customers.

 

In the meantime, fit-out of the new warehouse remains on track and we continue to target being operational early in 2021, although this date may still be affected by COVID-19 developments.

 

We will provide a further update when there is more clarity on the impact of COVID-19 on the Group.

 

Annual General Meeting

The 2020 Annual General Meeting will be held at 3pm today at Fairbrook House, Clover Nook Road, Alfreton, Derbyshire, DE55 4RF. As previously announced, and in line with Government guidance in relation to COVID-19, shareholders, proxies and other attendees will not be permitted to attend the AGM in person and shareholders have been strongly advised to vote by proxy. A facility to ask the directors questions by email was made available. Answers will be published, in due course, on the Company's website: www.eurocell.co.uk.

 

~~~~~~~~~~~~~~~~~~~~~~~

 

Enquiries:

Eurocell plc

Mark Kelly, Chief Executive Officer

+44 (0) 1773 842 105

 

Michael Scott, Chief Financial Officer

+44 (0) 1773 842 140

 

Teneo

Ben Foster

+44 (0) 777 624 0806

 

Camilla Cunningham

+44 (0) 7464 982 426

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCVXLFFBELFBBL
Date   Source Headline
7th Oct 20227:00 amRNSChanges to Board Committee memberships
5th Oct 20222:00 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSTotal Voting Rights
5th Sep 20227:00 amRNSBlock listing Interim Review
5th Sep 20227:00 amRNSInvestor Presentation
1st Sep 20227:00 amRNSHalf-year Report
15th Aug 20223:00 pmRNSHolding(s) in Company
10th Aug 20223:45 pmRNSAppointment to the Audit & Risk Committee
13th Jul 20227:00 amRNSTrading Update
5th Jul 202212:25 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
21st Jun 202212:08 pmRNSDirectorate Change
25th May 20227:00 amRNSBlock Listing Application
16th May 20227:00 amRNSDirector/PDMR Shareholding
12th May 20224:00 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update and Board Update
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
21st Mar 20227:00 amRNSInvestor Presentation
18th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Mar 20227:00 amRNSNotice of Results and Audiocast
15th Mar 20223:05 pmRNSTransaction in Own Shares
9th Mar 20225:00 pmRNSBlock listing Interim Review
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
21st Jan 20227:00 amRNSYear End Trading Update
4th Jan 20227:00 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSTrading Update November 2021
1st Nov 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTotal Voting Rights
7th Sep 20214:00 pmRNSInvestor Presentation
7th Sep 20211:38 pmRNSBlock listing Interim Review
3rd Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSTotal Voting Rights
2nd Aug 20217:00 amRNSTotal Voting Rights
20th Jul 20217:00 amRNSTrading Update
1st Jul 20217:00 amRNSTotal Voting Rights
1st Jun 20217:00 amRNSTotal Voting Rights
14th May 202111:18 amRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Update – Strong First Four Months
12th May 20216:13 pmRNSDirector/PDMR Shareholding
4th May 20217:00 amRNSTotal Voting Rights
26th Apr 20219:40 amRNSDirector/PDMR Shareholding
20th Apr 20217:00 amRNSBlock Listing Application
16th Apr 20211:10 pmRNSAnnual Financial Report
16th Mar 20211:39 pmRNSInvestor Presentation
12th Mar 20217:00 amRNSFinal Results
10th Mar 20217:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.